Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Diseases × sacituzumab govitecan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Triple Negative Breast Neoplasms 15 Carcinoma, Transitional Cell 5 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Neoplasm Metastasis 3 Salivary Gland Neoplasms 2 Colorectal Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Locally Advanced Non-resectable Breast Cancer 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm, Residual 1 Mouth Neoplasms 1 Metastatic Urothelial Cancer 1 Meningeal Carcinomatosis 1 Lung Diseases 1 Localized Muscle Invasive Bladder Urothelial Carcinoma 1 Liver Failure 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 HER2-negative Breast Cancer 1

Interventions

Carboplatin 4 Cisplatin 3 zipalertinib 1 zimberelimab 1 sacituzumab govitecan 1 repotrectinib 1 pembrolizumab 1 cemiplimab 1 alectinib 1 Vital Signs 1 Tomography, Emission-Computed, Single-Photon 1 Toll-Like Receptor 1 1 Telescopes 1 Radiotherapy 1 Radiosurgery 1 Pemetrexed 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Etoposide 1 Drug Delivery Systems 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06431633 2025-04-10

ARIAN

Fundación GECP

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡